Nanocomplexes of an insulinotropic drug: Optimization, microparticle formation, and antidiabetic activity in rats

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 4449-4465

  Elmowafy, Enas ^a   Osman, Rihab ^a   El Shamy, Abdel Hameed ^a   Awad, Gehanne A S ^a  

^a Ain Shams University   (Egypt)

Author keywords

Antidiabetic effect; Microparticles; Nanocomplexes; Nasal delivery; Spray drying

Indexed keywords

ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; DRUG CARRIER; GLUCOSE BLOOD LEVEL; MICROSPHERE; PIPERIDINE DERIVATIVE; REPAGLINIDE;

ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; INTRANASAL DRUG ADMINISTRATION; MALE; MEDICINAL CHEMISTRY; NOSE MUCOSA; WISTAR RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD GLUCOSE; CARBAMATES; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; HYPOGLYCEMIC AGENTS; MALE; MICROSPHERES; NASAL MUCOSA; PIPERIDINES; RATS, WISTAR;

EID: 84930260638     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S66876     Document Type: Article

References (41)

1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004;100:5–28.
2. Takashima Y, Saito R, Nakajima A, et al. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres. Int J Pharm. 2007;343(1): 262–269.
3. Trapani A, Sitterberg J, Bakowsky U, Kissel T. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs. Int J Pharm. 2009;375(1–2):97–106.
4. Dyer AM, Hinchcliffe M, Watts P, et al. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res. 2002;19(7):998–1008.
5. Panariti A, Miserocchi G, Rivolta I. The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl. 2012;5:87–100.
6. Gubbala SK. Polyelectrolyte complex: a pharmaceutical review. Int J Pharm Biol Sci. 2012;2(3):399–407.
7. Lund SS, Tarnow L, Stehouwer CD, et al. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab. 2007;9(3):394–407.
8. Makino C, Sakai H, Yabuki A. Nateglinide controlled release tablet containing compressionable enteric coated granules. Chem Pharm Bull. 2010;58(9):1136–1141.
9. Mandić Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal. 2006;41(3):866–871.
10. Jain S, Saraf S. Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus. J Diabetes. 2009;1(1):29–35.
11. Elmowafy E, Osman R, El-Shamy A, Awad GA. Nasal polysaccharides-glucose regulator microparticles: optimization, tolerability and antidiabetic activity in rats. Carbohyd Polym. 2014;108:257–265.
12. Kshirsagar SJ, Patel SJ, Madgulkar AR, Bhalekar MR. Formulation and in-vitro evaluation of repaglinide microspheres prepared by spray drying technique. Lat Am J Pharm. 2011;30(4):799–803.
13. Palazzo F, Giovagnoli S, Schoubben A, Blasi P, Rossi C, Ricci M. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin–palladium complex. Int J Pharm. 2013;440(2):273–282.
14. Gavini E, Hegge AB, Rassu G, et al. Nasal administration of car-bamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm. 2006;307(1):9–15.
15. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Del Rev. 2001;48(2–3):139–157.
16. Soliman M, Nasanit R, Abulateefeh SR, et al. Multicomponent synthetic polymers with viral-mimetic chemistry for nucleic acid delivery. Mol Pharm. 2012;9(1):1–13.
17. Sensoy D, Cevher E, Sarici A, Yilmaz M, Ozdamar A, Bergisadi N. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model. Eur J Pharm Biopharm. 2009;72(3):487–495.
18. Patil SB, Sawant KK. Chitosan microspheres as a delivery system for nasal insufflations. Colloids Surf B Biointerfaces. 2011;84(2): 384–389.
19. Nasr M, Awad GA, Mansour S, Taha I, Alshamy A, Mortada ND. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm. 2011;79(3):601–611.
20. Abu Abeeleh M, Ismail ZB, Alzaben KR, et al. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: a comparison between 2 strains of rats. Eur J Sci Res. 2009;32(3):398–402.
21. Pachisia N, Agrawal SS. Formulation, development and evaluation of transdermal drug delivery system of glimepiride. Int J Pharm Pharm Sci Res. 2012;2(1):1–8.
22. Rathnam G, Balasubramani P, Saravanakumar A. Nasal drug delivery of antidiabetic drug repaglinide using degradable starch microspheres. Int J Pharm Sci Res. 2011;2(4):940–947.
23. Bshara H, Osman R, Mansour S, El-Shamy A-H. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Carbohyd Polym. 2014;99: 297–305.
24. Ribeiro AJ, Silva C, Ferreira D, Veiga F. Chitosan reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur J Pharm Sci. 2005;25(1):31–40.
25. Xing J, Deng L, Dong A. Chitosan/alginate nanoparticles stabilized by poloxamer for the controlled release of 5-fluorouracil. J App Polym Sci. 2010;117(4):2354–2359.
26. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohyd Polym. 2008;73(1):44–54.
27. Mahmoud AA, El-Feky GS, Kamel R, Awad GE. 2011. Chitosan/ sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm. 2011;413(1–2):229–236.
28. Aramă C, Nicolescu C, Nedelcu A, Monciu C-M. Synthesis and characterization of the inclusion complex between repaglinide and sulfobutylether-β-cyclodextrin (Captisol®). J Incl Phenom Macrocycl Chem. 2011;70:421–428.
29. Ventura CA, Tommasini S, Crupi E, et al. Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies. Eur J Pharm Biopharm. 2008;68(2):235–244.
30. Shabbeer S, Shaheeda, Ramanamurthy KV. Formulation and evaluation of chitosan sodium alginate microcapsules of 5-fluorouracil for colorectal cancer. Int J Res Pharm Chem. 2012;2(1):7–19.
31. Sarmento B, Ferreira D, Veiga F, Ribeiro A. Characterization of insu-linloaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohyd Polym. 2006;66(1):1–7.
32. Li P, Dai YN, Zhang JP, Wang AQ, Wei Q. Chitosan-Alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci. 2008;4(3):221–228.
33. Seville PC, Learoyd TP, Li HY, Williamson IJ, Birchall JC. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol. 2007;178(1):40–50.
34. Kundawala AJ, Patel VA, Patel HV, Choudhary D. Influence of formulation components on aerosolization properties of isoniazid loaded chitosan microspheres. Int J Pharm Sci Drug Res. 2011;3(4):297–302.
35. Chen KH, Di Sabatino M, Albertini B, Passerini N, Kett VL. The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA. Eur J Pharm Sci. 2013; 50(3–4):312–322.
36. El-Gendy N, Gorman EM, Munson EJ, Berkland C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009;98(8):2731–2746.
37. Duhem N, Rolland J, Riva R, et al. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs. Int J Pharm. 2012;423(2):452–460.
38. Wong CF, Yuen KH, Peh KK. An in-vitro method for buccal adhesion studies: importance of instrument variables. Int J Pharm. 1999; 180(1):47–57.
39. Osman R, Kana PL, Awad G, Mortada N, EL-Shamy AE, Alpar O. Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity. Int J Pharm. 2013;449(1–2):44–58.
40. Yadav VK, Kumar B, Prajapati SK. Shafaat K. Design and evaluation of mucoadhesive microspheres of repaglinide for oral controlled release. Int J Drug Deliv. 2011;3:357–370.
41. Teijeiro-Osorio D, Remunan-Lopez C, Alonso MJ. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules. 2009;10(2):243–249.